Heart transplantation has become the accepted treatment for advanced heart failure, with
over 4000–5000 performed in the world annually. Although the number of yearly transplants …

The researches reviewed in this article support a significant improvement of the heart
preservation during the multifaceted process of procurement, transport, and transplant …

Heart Donation after Circulatory Death (DCD) has the potential to significantly increase the
number of patients benefitting from heart transplantation. However, the expansion of DCD …

Fifty years after the first successful heart transplantation, despite multiple advances in the
treatment of advanced acute and chronic heart failure, there is still no equivalent to heart …

The first human-to-human heart transplant was performed 50 years ago in 1967. Heart
transplantation has now entered an era of tremendous growth and innovation. The future of …

Heart transplantation remains the gold-standard therapy for end-stage heart failure; the
expected median survival range is 12–13 years. More than 30,000 heart transplants have …

Background the incidence of organ donation after circulatory death (DCD) is increasing;
however, heart use has lagged behind other solid organs. Ex vivo perfusion devices are …

Abstract Purpose of Review To highlight the current global experience with DCD heart
transplantation and explore the evolution of, and compare preservation strategies; examine …

Heart transplantation has in recent years become the treatment of choice for end stage heart
failure. However while the waiting list for transplantation is growing steadily, the donor pool …

Heart transplantation remains the definitive management for end-stage heart failure
refractory to medical therapy. While heart transplantation cases are increasing annually …